Pfizer Selects Biologics, Inc. as Limited Distribution Network Partner (LDN)

February 08, 2012 By: NCTechNews Category: Health Care

(Cary, N.C.) Biologics, Inc., an integrated oncology services company has been selected as a Limited Distribution Network (LDN) partner for Pfizer’s Inlyta which was approved by the FDA on January 27, 2012. Inlyta is indicated for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. Renal cell carcinoma is a type of kidney cancer that starts in the lining of very small tubes within the kidney. Inlyta works by blocking certain proteins called kinases that play a role in tumor growth and cancer progression. The recommended dose for Inlyta is 5mg taken orally two times a day. Clinical trial results showed a median progression-free survival of 6.7 months compared to 4.7 months with a standard treatment.

Biologics encompasses patient access, specialty pharmacy and care continuum services to provide a comprehensive solution that improves the patient experience and accelerates access to appropriate care. Recognized for its high-touch patient care model, Biologics’ oncology pharmacy services group includes a clinically relevant team with expertise in complex therapies to ensure patient adherence and compliance. As a result of its commitment to supporting cancer patients, Biologics has extensive prescriber relationships across the United States.

“It’s an honor to be selected as a Limited Distribution Network partner for Pfizer’s Inlyta,” said Stuart Frantz, Chief Executive Officer and President of Biologics, Inc. “We are committed to delivering the highest standard of care to patients and are excited to partner with Pfizer in providing another option to patients battling renal cell carcinoma.”

About Biologics: Biologics, Inc. is an integrated oncology services company with an innovative business model that brings together the many complex components of cancer care to provide a patient-focused platform for managing the financial, emotional and physical burdens of cancer treatment. Biologics is at the center of the rapidly changing oncology environment to support treatment modalities, clinical outcomes and informatics and leverage established relationships with oncology clinicians, patients, payors, researchers and manufacturers. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Biologics, Inc. is headquartered in Cary, N.C.

Comments are closed.

  • Controlling Quality

    An RTP firm is gaining international notoriety as a leader in analytical instrumentation for the pharmaceutical and chemical manufacturing industries, sharing innovative solutions to evolving pharmaceutical and chemical manufacturing challenges, presenting on emerging multi-variant approaches to obtaining immediate, unambiguous results from drug product samples at a recent major international tradeshow.

    Portable Power

    Alternative energy solutions provider INI Power Systems, Inc. recently marked its ten-year anniversary by unveiling the innovative new Trinity™ series of portable alternative energy hybrid solutions at two major events catering to the defense and emergency first responder marketplaces, with attendees searching for reliable, flexible power systems with multiple applications.

    EV Innovation

    Morrisville-based green transportation pioneer Evatran™ recently hosted a demonstration of its Plugless Power™ hands-free electric vehicle (EV) charging system, showcasing cost savings and convenience of EV usage in residential, commercial and public applications.

    guide to success

    Entrepreneurs now have a workbook to guide them through successful implementation of business building blocks thanks to a new goal-setting toolkit for personal and professional success available at no charge from a Cary-based international strategic business consultant.

    Packaging Cures

    RTP-based advertising and branding firm The Marketing Machine helped overcome the issue of illiteracy among medical patients in Ghana, South Africa in designing packaging for the only manufacturer of anti-retroviral drugs in the region, creating individual icons and colors to help patients understand which drugs they needed, regardless of their ability to read.

    Broadband Stimulus

    Two grants funded by the American Recovery and Reinvestment Act are being used by MCNC to expand broadband connectivity and services throughout North Carolina and create more than 1,000 engineering and construction jobs, the organization said.

  • Recent Headlines



free web site traffic and promotion